Table: begin end state 1 5 non-cytoplasmic 6 25 transmembrane 26 31 cytoplasmic 32 54 transmembrane 55 60 non-cytoplasmic 61 83 transmembrane 84 103 non-cytoplasmic 104 133 transmembrane 134 142 cytoplasmic 143 161 transmembrane 162 180 non-cytoplasmic 181 201 transmembrane 202 233 cytoplasmic 234 257 transmembrane 258 270 non-cytoplasmic 271 293 transmembrane 294 307 cytoplasmic 308 330 transmembrane 331 337 non-cytoplasmic 338 362 transmembrane 363 366 cytoplasmic 367 390 transmembrane 391 395 non-cytoplasmic 396 419 transmembrane 420 430 cytoplasmic 431 453 transmembrane 454 456 non-cytoplasmic
Input: >BPHYT_RS13375 MATVQGSLLLVYALIAIIALVVLIARFKMNPFITLMVVSVALALAVGMPATSILKSFETG VGGTLGHIAIVVGLGTMLGKMMAESGGAERIARTLIDLFGPKNVHWAMMCIAFLVGLPVF FEVGFVLLIPIAFNVAQRTGTSMIRVGIPMVAGLSVVHGLIPPHPAALLAVTAYNADIGH TIFYALIVGIPTAAIAGPLFSKLIARFVVLDGVNPMAQQFIEQDAKRSHQELPGFGITLL TVLLPVLLMLVGSWADLIVPAKSTANNVLRLIGHPDMALLLAVLLSFITFGKARGFNRDQ ILKFTNECLAPTASITLVVGAGAGFGRILIDSGASKAIVDVATGAHVPLLILAWLVAALI RVATGSATVAMATAAGIIAPIAAAAASTVGGVRPELLVLATGAGSLILSHVNDGGFWLVK EYFGMTVPQTFKTWTVCETIISVTALLLTLGLSTVI
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server